LUNG - NASDAQ

Pulmonx Corporation

Pulmonx Corporation

LUNGยทNASDAQ

$1.60

+1.9%
HealthcareMedical - Devices

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$67.79M
EPS-1.3300
P/E Ratio-1.21
Earnings Date07/29/2026
Pulmonx Corporation

Pulmonx Corporation Fair Value Envelope

LUNG ยท NASDAQ

Our analysis suggests that LUNG has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.605, this represents a potential HIDDEN relative to our calculated worth for Pulmonx Corporation.

HIDDEN
Intrinsic Value
Current Price: $1.605

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value-$221.1M
+ Cash & Equivalents$70.0M
Firm Value-$151.1M
- Debt$56.4M
Equity Value-$207.5M
/ Shares Outstanding40,746,556B
DCF Value-$5
OVERVALUED BY 417%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
-$32.5M
-$32.6M
-$32.7M
-$32.8M
-$32.9M
-$33.0M
-$33.0M
-$33.1M
-$33.2M
-$33.3M
Maintenance CapEx
-$90.6K
-$90.9K
-$91.1K
-$91.3K
-$91.6K
-$91.8K
-$92.1K
-$92.3K
-$92.5K
-$92.8K
Owner Earnings
-$32.6M
-$32.7M
-$32.8M
-$32.9M
-$33.0M
-$33.0M
-$33.1M
-$33.2M
-$33.3M
-$33.4M
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
-$30.2M
-$28.0M
-$26.0M
-$24.2M
-$22.4M
-$20.8M
-$19.3M
-$17.9M
-$16.7M
-$15.5M
Terminal Value represents 0.0% of Enterprise Value
Negative Owner Earnings
This company generates negative free cash flow. Consider adjusting maintenance CapEx percentage or check the financial data.

Related Guides

Blog Categories

Continue your LUNG research with focused valuation guides.

DCF Modeling

Improve assumptions for intrinsic value accuracy.

Forecasting

Calibrate growth paths and terminal value behavior.

WACC

Refine discount-rate logic for valuation quality.

Cost of Capital

Match risk profile to expected return assumptions.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.